Stem Cell Transplantation in Hemoglobinopathies

REFERENCES

• Lucarelli G, Clift AR. Marrow transplantation in thalassemia. Thomas' Hematopoetic Cell Transplantation 3rd, KG Blume, S Forman, FR Appelbaum. Blackwell Publishing, Malden 2004; 1409–1416
   Google Scholar
• Anonymous. Community control of hereditary anemias. Bull World Health Organ 1983; 61(1)63–80
   PubMed Web of Science ®Google Scholar
• Thomas ED, Buckner CD, Sanders JE, Papayannopoulou Th, Borgna-Pignatti C, De Stefano P, Sullivan KM, Clift RA, Storb R. Marrow transplantation for thalassemia. Lancet 1982; 2(8292)227–228
   PubMed Web of Science ®Google Scholar
• Gaziev D, Lucarelli G. Stem cell transplantation for hemoglobinopathies. Curr Opin Pediatr 2003; 15(1)24–31
   PubMed Web of Science ®Google Scholar
• Pakakasama S, Hongeng S, Chaisiripoomkere, Chuansumrit A, Sirachainun N, Jootar S. Allogeneic peripheral stem cell transplantation in children with homozygous β-thalassemia and severe β‐thalassemia/Hemoglobin E disease. J Pediatr Hematol Oncol 2004; 26(4)248–252
   PubMed Web of Science ®Google Scholar
• Yesilipek MA, Hazar V, Kópesiz A, Kizilors A, Uguz A, Yegin O. Peripheral blood stem cell transplantation in children with β thalassemia. Bone Marrow Transplant 2001; 28(11)1037–1040
   PubMed Web of Science ®Google Scholar
• Mentzer WC, Cowan MJ. Bone marrow transplantation for β-thalassemia: The University of California San Francisco experience. J Pediatr Hematol Oncol 2000; 22(6)598–601
   PubMed Web of Science ®Google Scholar
• Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Durazzi SM, Giardini C, Agostinelli F, Donai M, Girogi C. Bone marrow transplantation in patients with thalassemia. N Eng J Med 1990; 322(7)417–421
   PubMed Web of Science ®Google Scholar
• Sodani P, Gaziev D, Polchi P, Erer B, Giardini C, Angelucci E, Baronciani D, Andreani M, Manna M, Nesci S, Lucarelli B, Clift RA, Lucarelli G. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 2004; 104(4)1201–1203
   PubMed Web of Science ®Google Scholar
• Ramzi M, Nourani H, Zakemia M, Jahromi H. Hematopoietic stem cell transplantation for β-thalassemia major: experience in south of Iran. Transplant Proc 2004; 36(8)2509–2510
   PubMed Web of Science ®Google Scholar
• Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billigns FT, 3rd. Bone marrow transplantation in a patient with sickle cell anemia. N Engl J Med 1984; 311(12)780–783
   PubMed Web of Science ®Google Scholar
• Walters MC. Hematopoetic stem cell transplantation for sickle cell disease. Thomas' Hematopoetic Cell Transplantation 3rd, KG Blume, S Forman, FR Appelbaum. Blackwell Publishing, Malden 2004; 1417–1429
   Google Scholar
• Walters MC. Stem cell therapy for sickle cell disease: transplantation and gene therapy. Hematology Am Soc Hematol Educ Program 2005; 66–73
   PubMedGoogle Scholar
• La Nasa G, Argiolu F, Giardini C, Pesson A, Fagioli F, Caocci G, Vacca A, De Stefano P, Piras E, Leda A, Piroddi A, Littera R, Nesci S, Locatelli F. Unrelated bone marrow transplantation for β-thalassemia patients: the experience of the Italian Bone Marrow Transplant Group. Ann NY Acad Sci 2005; 1054: 186–195
   PubMed Web of Science ®Google Scholar
• Chen YH, Huang XJ, Chen H, Xu LP, Liu DH, Jiang Q, Zhang YC, Han W, Gao ZY, Wang JZ, Liu KY, Wu T, Lu DP. Analysis of 66 cases who received hematopoietic stem cell transplantation from unrelated donors. Zhonghua Yi Xue Za Zhi 2005; 26(11)656–660
   Google Scholar
• Feng Z, Sun E, Lan H, Zhang C, Li Q, Zhu W. Unrelated donor bone marrow transplantation for β‐thalassemia major: an experience from China. Bone Marrow Transplant 2006; 37(2)171–174
   PubMed Web of Science ®Google Scholar
• Hongeng S, Pakakasama S, Chaisiripoomkere W, Chuansumrit A, Sirachainan N, Ungkanont A, Jootar S. Outcome of transplantation with unrelated donor bone marrow in children with severe thalassaemia. Bone Marrow Transplant 2004; 33(4)377–379
   PubMed Web of Science ®Google Scholar
• Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, Brichard B, Li X, Nagler A, Giorgiani G, Haut PR, Brochstein JA, Nugent DJ, Blatt J, Woodard P, Kurtzberg J, Rubin CM, Miniero R, Lutz P, Raja T, Roberts I, Will AM, Yaniv I, Vermylen C, Tannoia N, Garnier F, Ionescu I, Walters MC, Lubin BH, Gluckman E, Eurocord Transplant Group. Related umbilical cord blood transplant in patients with thalassemia and sickle cell disease. Blood 2003; 101(6)2137–2143
   PubMed Web of Science ®Google Scholar
• Andreani M, Nesci S, Lucarelli G, Tonucci P, Rapa S, Angelucci E, Persini B, Agostinelli F, Donati M, Manna M. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant 2000; 25(4)401–404
   PubMed Web of Science ®Google Scholar
• Aker M, Kapelushnik J, Pugatsch T, Naparstek E, Ben-Neria S, Yehuda O, Amar A, Nagler A, Slavin S, Or R. Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for β-thalassemia major. J Pediatr Hematol Oncol 1998; 20(2)145–148
   PubMed Web of Science ®Google Scholar
• Collins RH, Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15(2)433–444
   PubMed Web of Science ®Google Scholar
• Angelucci E, Lucarelli G. Bone marrow transplantation in β thalassemia. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, MH Steinberg, BG Forget, DR Higgs, RL Nagel. Cambridge University Press, Cambridge 2001; 1052–1072
   Google Scholar
• Sullivan KM, Walters MC, Patience M, Leisenstring W, Buchanan GR, Castro O, Davies SC, Dickerhoff R, Eckman JR, Graham ML, Ohene-Frempong K, Powars D, Rogers Z, Scott JP, Styles L, Vichinsky E, Wall D, Wayne A, Wiley J, Wingard J, Bunin N, Camitta B, Darbyshire PJ, Dinndorf P, Klingebiel T, McMahon L, Mentzer WC, Olivieri N, Orringer E, Parkman R, Roberts IAG, Sanders JE, Smith F, Storb R. Collaborative study of marrow transplantation for sickle cell disease: aspects specific for transplantation of hemoglobin disorders. Bone Marrow Transplant 1997; 19(Suppl 2)102–105
   Google Scholar
• Walters MC. Hematopoetic stem cell transplantation for sickle cell disease. Thomas' Hematopoetic Cell Transplantation 3rd, KG Blume, S Forman, FR Appelbaum. Blackwell Publishing, Malden 2004; 1417–1429
   Google Scholar
• Vermylen C. Bone marrow transplantation in sickle cell anemia. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, MH Steinberg, BG Forget, DR Higgs, RL Nagel. Cambridge University Press, Cambridge 2001; 1073–1083
   Google Scholar
• Angelucci E, Muretto P, Nicolucci A, Baronciani D, Erer B, Gaziev J, Ripalti M, Sodani P, Tomassoni S, Visani G, Lucarelli G. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002; 100(1)17–21
   PubMed Web of Science ®Google Scholar
• Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B, Galimberti M, Giardini C, Gaziev D, Polchi P. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood 1997; 90(3)994–998
   PubMed Web of Science ®Google Scholar